Structure-Guided small molecule Drug Design & clinical development for rare diseases
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
Keywords: Pharmaceuticals, hereditary angioedema, influenza,